INVESTMENT AGREEMENT BY AND BETWEEN ENZON PHARMACEUTICALS, INC. AND ICAHN CAPITAL LP DATED AS OF SEPTEMBER 1, 2020Investment Agreement • September 1st, 2020 • Enzon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 1st, 2020 Company Industry JurisdictionThis Investment Agreement, dated as of September 1, 2020 (this “Agreement”), is by and between Enzon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Icahn Capital LP, a Delaware limited partnership (the “Investor”).
INVESTMENT AGREEMENT BY AND BETWEEN ENZON PHARMACEUTICALS, INC. AND ICAHN CAPITAL LP DATED AS OF SEPTEMBER 1, 2020Investment Agreement • September 1st, 2020 • Enzon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 1st, 2020 Company Industry JurisdictionThis Investment Agreement, dated as of September 1, 2020 (this “Agreement”), is by and between Enzon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Icahn Capital LP, a Delaware limited partnership (the “Investor”).